T-THERAPEUTICS LIMITED

14097070
Active United Kingdom

Research and experimental development on biotechnology

69 employees website.com
Life sciences and medical technology Research and experimental development on biotechnologyOther research and experimental development on natural sciences and engineering
T

T-THERAPEUTICS LIMITED

14097070

Research and experimental development on biotechnology

Founded 10 May 2022 Active United Kingdom 69 employees website.com
Life sciences and medical technology Research and experimental development on biotechnologyOther research and experimental development on natural sciences and engineering
Accounts Due 30 Sept 2026 3 months remaining
Confirmation Submitted 9 Jun 2026 Next due 6 Jun 2027 11 months remaining
Net assets £13M £4M 2024 year on year
Total assets £16M £6M 2024 year on year
Total Liabilities £3M £2M 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Email

info@example.com

Website

www.example.com

Full company profile for T-THERAPEUTICS LIMITED (14097070), an active life sciences and medical technology company based in United Kingdom. Incorporated 10 May 2022. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type group
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£8.73M

Increased by £3.07M (+54%)

Net Assets

£13.16M

Increased by £3.85M (+41%)

Total Liabilities

£3.32M

Increased by £2.06M (+164%)

Turnover

N/A

Employees

69

Increased by 36 (+109%)

Debt Ratio

20%

Increased by 8 (+67%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (6)

Investor NameInvestor SinceParticipating Rounds
Investor 1Nov 2023Series A
Investor 2Nov 2023Series A
Investor 3Nov 2023Series A

Share Capital

Share Capital

Share allotments and capital structure

17 Allotments 701,481,433 Shares £57.24m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Apr 202657,748£0.058£0
21 Apr 20269,649£0.005£0.005
18 Mar 202652,058£0.005£0.005
18 Mar 202624,646£0.025£0
13 Jan 2026299,382£0.299£0

Officers

Officers

3 active
Status
Bradley, Allan, DrDirectorBritishUnited Kingdom6610 May 2022Active
Harold, TheodoraDirectorBritishUnited Kingdom529 May 2025Active
Robert Giles TansleyDirectorBritishEngland6215 Nov 2022Active

Shareholders

Shareholders (16)

Sofinnova Capital X
29.6%
109,336,105
F-prime Capital Partners Life Sciences Fund Vii Lp
19.1%
70,539,424

Persons with Significant Control

Persons with Significant Control (0)

0 Active 1 Ceased

Allan Bradley

Ceased 14 May 2025

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
One Granta, Granta Park, Great Abington, Cambridge (CB21 6DP) SOUTH CAMBRIDGESHIRE
Leasehold-18 Sept 2024
One Granta, Granta Park, Great Abington, Cambridge (CB21 6DP)
Leasehold
Added 18 Sept 2024
District SOUTH CAMBRIDGESHIRE

Documents

Company Filings

DateCategoryDescriptionDocument
9 Jun 2026Confirmation StatementConfirmation statement made on 23 May 2026 with updates
29 Apr 2026CapitalAllotment of shares (GBP 752.893327) on 21 Apr 2026
16 Apr 2026CapitalAllotment of shares (GBP 752.82593) on 31 Mar 2026
16 Feb 2026CapitalAllotment of shares (GBP 752.749226) on 13 Jan 2026
9 Dec 2025OfficersAppointment of Viet-Anh Anne Horgan as director on 1 Dec 2025
9 Jun 2026 Confirmation Statement

Confirmation statement made on 23 May 2026 with updates

29 Apr 2026 Capital

Allotment of shares (GBP 752.893327) on 21 Apr 2026

16 Apr 2026 Capital

Allotment of shares (GBP 752.82593) on 31 Mar 2026

16 Feb 2026 Capital

Allotment of shares (GBP 752.749226) on 13 Jan 2026

9 Dec 2025 Officers

Appointment of Viet-Anh Anne Horgan as director on 1 Dec 2025

Recent Activity

Latest Activity

Confirmation statement made on 23 May 2026 with updates

2 weeks ago on 9 Jun 2026

Allotment of shares (GBP 752.893327) on 21 Apr 2026

1 months ago on 29 Apr 2026

Allotment of shares (GBP 752.82593) on 31 Mar 2026

2 months ago on 16 Apr 2026

Allotment of shares (GBP 752.749226) on 13 Jan 2026

4 months ago on 16 Feb 2026

Appointment of Viet-Anh Anne Horgan as director on 1 Dec 2025

6 months ago on 9 Dec 2025